Monograph Details
|
|
Immune System
> Immunization
|
|
MENACTRA |
| Manufacturer |
|
Sanofi Pasteur, Inc. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Neisseria meningitidis polysaccharides 4mcg each of Group A, C, Y, and W-135; per 0.5mL; (diphtheria toxoid conjugate); soln for IM inj; preservative-free. |
| Indications |
|
Meningitis immunization. |
| Adults and Children |
|
Give by IM inj only in deltoid region. 2–55yrs: 0.5mL once. |
| Contraindications |
|
Latex allergy. History of Guillain-Barre syndrome. |
| Precautions |
|
Have epinephrine inj (1:1000) available. Immunosuppressed. Acute illness. Coagulation disorders. Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Immunosuppressants (eg, irradiation, antimetabolites, alkylating agents, cytotoxic drugs, high-dose steroids) may get suboptimal response. Concomitant vaccines: see literature. |
| Adverse Reactions |
|
Local reactions, headache, fatigue, malaise, arthralgia, GI upset, anorexia, chills, fever, rash, irritability, drowsiness. |
| Extra Text |
|
Note: To register pregnant patients or to report adverse events call (800) 822-2463. Refer to www.cdc.gov for ACIP guidelines on vaccinating acutely ill patients. |
| How Supplied |
Vials—5
Syringes—5 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
